Edition:
United States

Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

29.13USD
24 Apr 2017
Change (% chg)

$1.11 (+3.96%)
Prev Close
$28.02
Open
$28.30
Day's High
$29.65
Day's Low
$28.18
Volume
501,409
Avg. Vol
391,272
52-wk High
$41.69
52-wk Low
$23.07

Select another date:

Thu, Mar 16 2017

BRIEF-Acceleron to initiate phase 2 trial of ACE-083 in charcot-marie-tooth neuromuscular disease

* Acceleron announces plans to initiate a phase 2 trial of ACE-083 in charcot-marie-tooth neuromuscular disease and host educational webinar

BRIEF-Acceleron outlines corporate goals and priorities for 2017

* Plan to initiate new luspatercept phase 2 clinical trials in distinct patient segments in MDS and Beta-Thalassemia

BRIEF-Acceleron Pharma reports Q3 financial and operational results

* Acceleron Pharma reports third quarter 2016 financial and operational results Source text for Eikon: Further company coverage:

Select another date:

More From Around the Web